Results 151 to 160 of about 294,860 (217)

Harnessing Sequence Embedding and Ensemble Learning to Identify Antifungal Peptides with Low Hemolytic Risk. [PDF]

ACS Omega
Lin CY, Cheng WC, Chen UL, Lin TT, Hsu LH, Shih YH, Lu IH, Chen YL, Chen SH.   +8 more
europepmc   +1 more source

Uncommon aortic prosthesis vegetation due to <i>Histoplasma capsulatum</i>: clinical and laboratory aspects. [PDF]

Med Mycol Case Rep
de Lima-Neto RG, Jucá MB, de Albuquerque Gomes TC, Roberta Soares Rodrigues K, Inácio CP, Neves RP.   +5 more
europepmc   +1 more source

Antifungal Potential of <i>Bacillus</i> spp., <i>Streptomyces</i> spp. and <i>Trichoderma asperellum</i> Against Phytopathogenic Fungi. [PDF]

Pathogens
Seņkovs M, Nikolajeva V, Rubene L, Jauga K, Zemeca L, Jakobija I.   +5 more
europepmc   +1 more source

Design of Multifunctional Bioactive Peptides for Potential Application in Food Packaging: A Machine-Learning-Integrated Optimization Framework. [PDF]

ACS Omega
Gunapati SNR, Gunaseelan SK, Dutta A, Mitra D.   +3 more
europepmc   +1 more source

Changing Pattern of Peritoneal Dialysis-Related Fungal Peritonitis: A 21-Year Single-Center Experience. [PDF]

Kidney Med
Yan H, Zhang H, Qian Y, Su X, Shen Y, Huang J, Ni Z, Gu L, Fang W.   +8 more
europepmc   +1 more source

Emerging evidence for anti-PD-1 and IFN-γ as adjunctive immunotherapy in invasive mold infections. [PDF]

mBio
Serris A, Guihot A, Joffre J, Dessajan J, Dahuron L, Bosch A, Dudoignon E, Pierot L, Lelièvre L, Lukaszewicz AC, Monneret G, Lambotte O, Martin-Blondel G, Lanternier F.   +13 more
europepmc   +1 more source

Advances in cryptococcal infections-associated immunopathology and potential therapeutic strategies. [PDF]

Front Pharmacol
Sachivkina N, Saha S, Gurina R, Kuznetsova O, Zhabo N, Avdonina M, Pilshchikova O.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Antifungal discovery

Current Opinion in Microbiology, 2022
Fungi have a profound impact on human health, leading to billions of infections and millions of deaths worldwide each year. Exacerbating the public health burden is the continued emergence of drug-resistant fungal pathogens coupled with a dearth of treatment options to combat serious infections.
Nicole, Robbins, Leah E, Cowen
openaire   +2 more sources

Antifungals

Biochemical Pharmacology, 2017
The need for new antifungal agents is undeniable. Current therapeutic choices for the treatment of invasive fungal infections are limited to three classes of drugs. Most used antifungal agents are not completely effective due to the development of resistance, host toxicity and undesirable side effects that limit their use in medical practice.
Sonia, Campoy, José L, Adrio
openaire   +2 more sources